The metabolic basis of kidney cancer
WM Linehan, LS Schmidt, DR Crooks, D Wei… - Cancer Discovery, 2019 - AACR
Kidney cancer is not a single disease but represents several distinct types of cancer that
have defining histologies and genetic alterations and that follow different clinical courses …
have defining histologies and genetic alterations and that follow different clinical courses …
New and emerging renal entities: a perspective post‐WHO 2016 classification
K Trpkov, O Hes - Histopathology, 2019 - Wiley Online Library
Renal tumours include a heterogeneous and diverse spectrum of neoplasms. Recent
advances in this field have significantly improved our understanding of the morphological …
advances in this field have significantly improved our understanding of the morphological …
Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma
Renal medullary carcinoma (RMC) is a highly lethal malignancy that mainly afflicts young
individuals of African descent and is resistant to all targeted agents used to treat other renal …
individuals of African descent and is resistant to all targeted agents used to treat other renal …
Circulating tumor DNA as a biomarker in patients with stage III and IV Wilms tumor: analysis from a Children's Oncology Group Trial, AREN0533
LM Madanat-Harjuoja, LA Renfro, K Klega… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The utility of circulating tumor DNA (ctDNA) analyses has not been established in
the risk stratification of Wilms tumor (WT). We evaluated the detection of ctDNA and selected …
the risk stratification of Wilms tumor (WT). We evaluated the detection of ctDNA and selected …
Systemic therapies for the management of non–clear cell renal cell carcinoma: what works, what doesn't, and what the future holds
P Zoumpourlis, G Genovese, NM Tannir… - Clinical genitourinary …, 2021 - Elsevier
Non–clear cell renal cell carcinoma (nccRCC) is a broad term that refers to a diverse group
of tumors, each with its own distinct biologic and therapeutic profile. The management of …
of tumors, each with its own distinct biologic and therapeutic profile. The management of …
Minimal infiltrative disease identification in cryopreserved ovarian tissue of girls with cancer for future use: a systematic review
M Grubliauskaite, MEM van der Perk, AME Bos… - Cancers, 2023 - mdpi.com
Simple Summary Cryopreservation of ovarian tissue and transplantation are the only
available fertility techniques to preserve fertility and endocrine function for prepubertal girls …
available fertility techniques to preserve fertility and endocrine function for prepubertal girls …
Characteristics and outcome of children with renal cell carcinoma: a narrative review
JN van der Beek, JI Geller, RR de Krijger, N Graf… - Cancers, 2020 - mdpi.com
Pediatric renal cell carcinoma (RCC) is a rare type of kidney cancer, most commonly
occurring in teenagers and young adolescents. Few relatively large series of pediatric RCC …
occurring in teenagers and young adolescents. Few relatively large series of pediatric RCC …
Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93‐01, 2001 and UK …
JN van der Beek, JA Hol… - … Journal of Cancer, 2021 - Wiley Online Library
In children, renal cell carcinoma (RCC) is rare. This study is the first report of pediatric
patients with RCC registered by the International Society of Pediatric Oncology‐Renal …
patients with RCC registered by the International Society of Pediatric Oncology‐Renal …
MicroRNA‐204‐5p: A novel candidate urinary biomarker of Xp11. 2 translocation renal cell carcinoma
R Kurahashi, T Kadomatsu, M Baba, C Hara… - Cancer …, 2019 - Wiley Online Library
Xp11. 2 translocation renal cell carcinoma (Xp11 tRCC) is a rare sporadic pediatric kidney
cancer caused by constitutively active TFE 3 fusion proteins. Tumors in patients with Xp11 …
cancer caused by constitutively active TFE 3 fusion proteins. Tumors in patients with Xp11 …
[HTML][HTML] Systemic treatment for advanced and metastatic non-clear cell renal cell carcinoma: Examining modern therapeutic strategies for a notoriously challenging …
J Drobner, D Portal, K Runcie, Y Yang… - Journal of Kidney …, 2023 - ncbi.nlm.nih.gov
Non-clear cell renal cell carcinoma (nccRCC) is a heterogeneous group of malignancies
that represents 25% of renal cell carcinoma (RCC) cases. Treatment for non-clear cell …
that represents 25% of renal cell carcinoma (RCC) cases. Treatment for non-clear cell …